Each vial contains highly pure FOXO4-DRI, a modified peptide that disrupts the FOXO4–p53 interaction in senescent cells. FOXO4-DRI is studied as a senolytic candidate in longevity research for its ability to selectively induce apoptosis in aged, dysfunctional cells while sparing healthy tissue.
Each vial contains highly pure FOXO4-DRI, a modified peptide that disrupts the FOXO4–p53 interaction in senescent cells. FOXO4-DRI is studied as a senolytic candidate in longevity research for its ability to selectively induce apoptosis in aged, dysfunctional cells while sparing healthy tissue.
| Strength | 10mg |
|---|---|
| Pack | Single Vial, Box of 10 |
Reviews
There are no reviews yet.